Respublikine Klaipedos ligonine VÅ¡Ä®
- Address
- Bangų g. 6A, LT-91251 Klaipėda, Lithuania
Respublikine Klaipedos ligonine VÅ¡Ä® - Mental Health Research
Respublikine Klaipedos ligonine VÅ¡Ä® is a clinical research center in Lithuania dedicated to advancing treatment options for psychiatric disorders. The center specializes in evaluating novel therapeutic approaches for patients with mood disorders, focusing on innovative adjunctive treatments that can enhance outcomes for individuals who may not achieve adequate response with standard therapies.
- Major Depressive Disorder treatment evaluation
- Novel pharmacological interventions for depression
- Assessment of adjunctive therapies for mood disorders
The center conducts rigorous efficacy and safety assessments using standardized psychiatric rating scales, including the Montgomery-Asberg Depression Rating Scale (MADRS), to measure treatment outcomes in Major Depressive Disorder. Their research contributes to the development of next-generation treatments that may offer new hope for patients with treatment-resistant depression.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Neurocrine Biosciences Inc.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 79 other sites in Lithuania
Therapeutic Area Benchmark — Lithuania
Select a therapeutic area to compare against other sites in Lithuania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Lithuania
Market Share
Country: Lithuania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Respublikine Klaipedos ligonine VÅ¡Ä®
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of NBI-1065845 as Adjunctive Therapy in Adults with Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial | Neurocrine Biosciences Inc. | Phase III | Recruiting | Oct 2025 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| 9-(4-CYCLOHEXYLOXYPHENYL)-7-METHYL-3,4-DIHYDROPYRAZINO[2,1-C][1,2,4]THIADIAZINE 2,2-DIOXIDE | 1 | Unknown | 2025-10-22 | 2025-10-22 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.